Coxsackievirus B3 clinical isolates and murine myocarditis

By Gauntt C.J.   Pallansch M.A.  

Virus Research, Vol. 45, Iss. 1, 1996-11 ,pp. : 69-69

Elsevier

Access to resources Recommend Favorite

The Coxsackie-Adenovirus Receptor (CAR) Is Used by Reference Strains and Clinical Isolates Representing All Six Serotypes of Coxsackievirus Group B and by Swine Vesicular Disease Virus

By Martino T.A.   Petric M.   Weingartl H.   Bergelson J.M.   Opavsky M.A.   Richardson C.D.   Modlin J.F.   Finberg R.W.   Kain K.C.   Willis N.   Gauntt C.J.   Liu P.P.  

Virology, Vol. 271, Iss. 1, 2000-05 ,pp. : 99-108

Elsevier

Access to resources Recommend Favorite

Genotypic variation in Coxsackievirus B5 isolates from three different outbreaks in the United States

By Kopecka H.   Brown B.   Pallansch M.  

Virus Research, Vol. 38, Iss. 2, 1995-10 ,pp. : 125-136

Elsevier

Access to resources Recommend Favorite

MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation

By Liu Yan   Wu WeiFeng   Xue Yimin   Gao Mengsha   Yan Yuluan   Kong Qing   Pang Yu   Yang Fan  

Archives of Virology, Vol. 158, Iss. 9, 2013-09 ,pp. : 1953-1963

Springer Publishing Company

Access to resources Recommend Favorite

Attachment of Coxsackievirus B3 Variants to Various Cell Lines: Mapping of Phenotypic Differences to Capsid Protein VP1

By Schmidtke M.   Selinka H.-C.   Heim A.   Jahn B.   Tonew M.   Kandolf R.   Stelzner A.   Zell R.  

Virology, Vol. 275, Iss. 1, 2000-09 ,pp. : 77-88

Elsevier

Access to resources Recommend Favorite